David S. Barlow is 10% at Molecular Insight Pharmaceuticals, Inc. (MIPI). They have made 8 open-market trades across 1 company since 2000, most recently 2011-01-28.
CIK 0001299065
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $144K since 2007, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIPI | SELL | 2011-01-27 | 2011-01-28 | $0.17 | $16K | N/A | N/A | N/A |
| MIPI | SELL | 2010-12-16 | 2010-12-20 | $0.20 | $40K | N/A | N/A | N/A |
| MIPI | SELL | 2010-01-12 | 2010-01-21 | $2.03 | $16K | N/A | N/A | N/A |
| MIPI | SELL | 2009-12-23 | 2009-12-28 | $2.36 | $33K | N/A | N/A | N/A |
| MIPI | SELL | 2009-12-18 | 2009-12-28 | $2.30 | $13K | N/A | N/A | N/A |
| MIPI | BUY | 2007-11-30 | 2007-12-04 | $8.49 | $42K | N/A | N/A | N/A |
| MIPI | BUY | 2007-11-20 | 2007-11-21 | $6.79 | $102K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2007-01-03 | 2007-01-03 | $54.83 | $548K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-12-01 | 2006-12-05 | $49.01 | $490K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-05-18 | 2006-05-19 | $29.21 | $292K | N/A | N/A | N/A |
| NRPH | SELL · 10b5-1 | 2006-03-20 | 2006-03-22 | $30.86 | $309K | N/A | N/A | N/A |
| MIPI | SELL | 2000-12-23 | 2010-01-06 | $2.42 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.